Skip to main content
. 2022 Mar 6;10(6):1569–1576. doi: 10.1016/j.jaip.2022.02.027

Table III.

Exacerbation rates before and during COVID-19 (n = 7,805)

Outcome Rate before COVID-19 (mean [SE]) Rate during COVID-19 (mean [SE]) Ratio of rates before vs during COVID-19 (95% confidence interval) P
All exacerbations 0.264 (0.009) 0.214 (0.009) 0.810 (0.739-0.888) <.001
Prednisone 0.213 (0.008) 0.169 (0.008) 0.794 (0.718-0.878) <.001
Any inpatient visit 0.004 (0.001) 0.002 (0.001) 0.478 (0.238-0.960) .04
Any emergency department visit 0.017 (0.002) 0.015 (0.002) 0.874 (0.650-1.175) .37
Any urgent care visit 0.025 (0.002) 0.023 (0.002) 0.903 (0.717-1.137) .39
Portion of days covered 0.528 (0.004) 0.539 (0.004) 1.022 (1.010-1.033) <.001
Asthma medication ratio§ 0.755 (0.003) 0.762 (0.003) 1.035 (1.006-1.064) .019

Poisson model accounting for repeated measures unadjusted for covariates. The ratio with the confidence interval is the incidence density ratio.

Generalized linear model using log-binomial model accounting for repeated measures unadjusted for covariates. The reported ratio and confidence interval are the relative risk.

Rates are adjusted for person-years except for the asthma medication ratio, which is not dependent on time.

§

Odds ratio for logit model with fractional-dependent variable accounting for repeated measures.